Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer

PHASE4RecruitingINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

April 20, 2020

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Recurrent or Metastatic Colorectal Cancer
Interventions
DRUG

Aflibercept + FOLFIRI

"Day 1. Aflibercept + FOLFIRI~* aflibercept(Zaltrap): 4 mg/kg IV infusion for over 1hr (Do not administer as an IV push or bolus)~* Folinic acid: 400 mg/m2 IV infusion for over 2 hours~* Irinotecan: 150 mg/m2 IV infusion for over 1 hours~* 5-FU: 400 mg/m2 IV bolus injection for over 5 minute~* 5-FU: 2400 mg/m2 IV continuous infusion for 46 hours every 2 weeks until progression disease or death or unacceptable toxicity"

Trial Locations (1)

Unknown

RECRUITING

Yonsei University, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER